(RTTNews) - Shares of Eiger BioPharmaceuticals Inc. (EIGR) are down 44 percent from their 52-week high of $15.82, recorded on December 26, 2019, and trade around $8.00. Eiger is a late-stage ...
A University of Maryland-led discovery could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with no known cure that causes ...
The results of a University of Maryland (UMD)-led study could point to new and improved treatment approaches for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes ...
PALO ALTO, Calif., Jan. 25, 2021 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of ...
The gene-editing method known as base editing might be a way to address the underlying cause of Hutchinson-Gilford progeria syndrome (HGPS or progeria), a rare genetic disease that leads to ...
When Sammy Basso was diagnosed with progeria at 2, it seemed likely that the disease’s hyper-accelerated aging would kill him before he graduated high school. “There was nothing. Nothing. No cure, of ...
Jan H. J. Hoeijmakers is in the Molecular Genetics Department, Erasmus MC, 3015 GD Rotterdam, the Netherlands, and also at the Princess Máxima Center for Pediatric Oncology, Oncode Institute and at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results